Dailypharm Live Search Close

Decreased commitment to production/sales/new generics

By Lee, Jeong-Hwan | translator Kim, Jung-Ju

23.04.10 05:50:56

°¡³ª´Ù¶ó 0
Ministry of Health and Welfare, full-fledged public-private consultative body for first in class and generics

Prospects for policy announcements in the first half of the year


"Financial expenses for health insurance drugs are calculated by multiplying volume and price. The government has been engrossed in finding reasons for reducing drug prices and establishing policies for decades while neglecting efforts to reduce usage."

"(To the government), it seems that the price adjustment of generic drugs is always recognized as the easiest and easiest way. For pharmaceutical companies that are constantly striving to create new drugs, generics are the driving force. Only pharmaceutical companies that do not directly produce drugs or do research and development Please consider the hard way to regulate tweezers." Domestic pharmaceutical companies are becoming more concerned as the Min

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)